Biofilms can be very resistant to antibiotics and have been known to contribute to a variety of infectious diseases. Biofilms have known to contribute to infections such as urinary tract infections, middle-ear infections, heart infections, bacterial vaginosis, and infections from medical devices such as catheters and implants. These infections sometimes require a high dose of antibiotics to fully rid the body of the bacteria.
Biofilms can form almost anywhere. Biofilms thrive around surfaces that are warm and moist, providing a habitable home for new generations of bacteria. In human environments, biofilms can easily grow in showers, sinks, open wounds, surgical sites, and medical devices such as catheters and implants.
We at Biofloze developed a novel biofilm removing technology with the collaboration of academic researchers at the University at Buffalo. If a standardized treatment is performed only once on a biofilm, it is expected that the biofilm would re-establish itself and continue to thrive. So a sustained release of the biofilm removal technology, over a period of time, will be ideal for preventing the biofilm from re-establishing. A sustained removal of biofilm ensures effective treatment of infection. With the utilization of state-of-the-art nanotechnology, along with our existing biofilm removal techonology, we are advancing the fight against infection to a different level.